510(k) Report

510(k) · Cleared

Cleared

Stelo Glucose Biosensor System

K260935510(k) TraditionalCleared Jun 12, 202684-day reviewClass II21 CFR 862.1355

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Dexcom, Inc. · SBH Integrated Continuous Glucose Monitor For Non-Intensive Glucose Management, Over-The-Counter

Cleared on Jun 12, 2026 as substantially equivalent to K234070 (Dexcom, Inc., 2024) after an 84-day review. Its family tree reaches back 8 generations to 2018. 1 of the 12 devices in its family, counting itself, has a Class I recall. 1 later device descends from it.

Decided
Jun 12, 2026
Review
84 days
Class
Class II
Product code
SBH
Recalls
None
Predicates
1

Its longest line of descent runs back 8 generations to DEN170088 (2018). 10 ancestors in all. 1 later device descends from it, 1 citing it directly. 1 of the 12 devices in this family, counting this one, has a Class I recall.

  1. Root · 8 generations backDEN170088 Dexcom G6 Continuous Glucose Monitoring SystemDexcom, Inc. · 2018
  2. 7 generations backK182041 Dexcom G6 Glucose Program Continuous Glucose Monitoring SystemDexcom, Inc. · 2018
  3. 6 generations backK191450 Dexcom G6 Continuous Glucose Monitoring System, Dexcom G6 Glucose…Dexcom, Inc. · 2019 · Recalled
  4. 5 generations backK200876 Dexcom G6 Continuous Glucose Monitoring System, Dexcom G6 Glucose…Dexcom, Inc. · 2020 · Recalled
  5. 4 generations backK201328 Dexcom G6 Continuous Glucose Monitoring (CGM) SystemDexcom, Inc. · 2021
  6. 3 generations backK213919 Dexcom G7 Continuous Glucose Monitoring SystemDexcom, Inc. · 2022 · Recalled (Class I)
  7. 2 generations backK231081 Dexcom G7 Continuous Glucose Monitoring (CGM) SystemDexcom, Inc. · 2023 · Recalled
  8. 1 generation backK234070 Stelo Glucose Biosensor SystemDexcom, Inc. · 2024
  9. This deviceK260935 Stelo Glucose Biosensor SystemDexcom, Inc. · 2026
  10. Descendant · cites it directly · 0 of its ownK262472 Stelo Glucose Biosensor SystemDexcom, Inc. · 2026

Class I recalls in this family

Most influential descendants

Showing 1 of 1 · See all
  • K262472Stelo Glucose Biosensor SystemDexcom, Inc. · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−8DEN170088Dexcom G6 Continuous Glucose Monitoring SystemDexcom, Inc.2018—
−7K182041Dexcom G6 Glucose Program Continuous Glucose Monitoring SystemDexcom, Inc.2018—
−6K191450Dexcom G6 Continuous Glucose Monitoring System, Dexcom G6 Glucose Program…Dexcom, Inc.20192
−5K200876Dexcom G6 Continuous Glucose Monitoring System, Dexcom G6 Glucose Program…Dexcom, Inc.20201
−4K201328Dexcom G6 Continuous Glucose Monitoring (CGM) SystemDexcom, Inc.2021—
−3K213919Dexcom G7 Continuous Glucose Monitoring SystemDexcom, Inc.2022Class I
−2K231081Dexcom G7 Continuous Glucose Monitoring (CGM) SystemDexcom, Inc.20231
−1K234070Stelo Glucose Biosensor SystemDexcom, Inc.2024—
0 (this device)K260935Stelo Glucose Biosensor SystemDexcom, Inc.2026—
+1K262472Stelo Glucose Biosensor SystemDexcom, Inc.2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
201810
201910

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202610
FIG. 1 — Lineage of K260935, 2018–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new SBH device

  1. #1 K262472 Stelo Glucose Biosensor Systemscore 14.2 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K234070Stelo Glucose Biosensor System
Summary page 6
…ibrated Regulation Number 21 CFR 862.1355 Product Code SBH Legally Marketed Predicate Device: Predicate # K234070 Predicate Trade Name Stelo Glucose Biosensor System Product Code SAF Legally Marketed Reference De…
Dexcom, Inc.2024—
†K213919Dexcom G7 Continuous Glucose Monitoring SystemDexcom, Inc.2022Class I
†K234133Dexcom G7 Continuous Glucose Monitoring SystemDexcom, Inc.2024—
†K243214Dexcom G7 15 Day Continuous Glucose Monitoring SystemDexcom, Inc.20252

Also cleared against K234070: 2 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K262472Stelo Glucose Biosensor SystemDexcom, Inc.20260

Has anything in its family been recalled? (1 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K213919Dexcom G7 Continuous Glucose Monitoring SystemDexcom, Inc. · 2022 · 3 generations back · ◆ on the line of descent in FIG. 14 Class I recalls

What does this lineage say?

  • The line of descent spans 8 years and passes through 1 company; a new generation was cleared every 10 months on median.
  • 4 of the 10 ancestors have a recall of any class; 1 has a Class I recall.
  • Of its descendants, K262472 (Dexcom, Inc., 2026) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate K234070.

How does its category compare?

All SBH devices

SBH Integrated Continuous Glucose Monitor For Non-Intensive Glucose Management, Over-The-Counter: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · SBH

2so far in 2026, the most since 2007

2024: 12026 (partial year): 2
2007high 2 (2026) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · SBH

Too few SBH 510(k)s in any year since 2007 to give a median.

Recalls per year · SBH

No recall names SBH since 2007.

Adverse event reports per year · SBH

1in 2025

2024: 12025: 1
2007high 1 (2024) · low 0 (2007)2025

MAUDE reports naming product code SBH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20241—01
20250—01
20262—0—

What is it indicated for?

The Stelo Glucose Biosensor System is an over-the-counter (OTC) integrated Continuous Glucose Monitor (iCGM) intended to continuously measure, record, analyze, and display glucose values in people 2 years and older not on insulin. The Stelo Glucose Biosensor System helps to detect normal (euglycemic) and low or high (dysglycemic) glucose levels. The Stelo Glucose Biosensor System may also help the user better understand how lifestyle and behavior modification, including diet and exercise, impact glucose excursion.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K260935: Stelo Glucose Biosensor System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K260935

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded Oct 30, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026